TY - JOUR AU - Lanthier, M. AU - Miller, K. L. AU - Nardinelli, C. PY - 2013 DA - 2013// TI - An improved approach to measuring drug innovation finds steady rates of first-in-class pharmaceuticals, 1987–2011 JO - Health Aff (Millwood) VL - 32 UR - https://doi.org/10.1377/hlthaff.2012.0541 DO - 10.1377/hlthaff.2012.0541 ID - Lanthier2013 ER - TY - JOUR AU - Schwartz, L. M. AU - Woloshin, S. PY - 2011 DA - 2011// TI - Communicating uncertainties about prescription drugs to the public a national randomized trial JO - Arch Intern Med VL - 171 UR - https://doi.org/10.1001/archinternmed.2011.396 DO - 10.1001/archinternmed.2011.396 ID - Schwartz2011 ER - TY - BOOK PY - 2013 DA - 2013// TI - Drug Utilisation Sub-Committee Outcome Statement 7–8 ID - ref3 ER - TY - JOUR AU - Sobrero, A. AU - Bruzzi, P. PY - 2009 DA - 2009// TI - Incremental advance or seismic shift? The need to raise the bar of efficacy for drug approval JO - J Clin Oncol VL - 27 UR - https://doi.org/10.1200/JCO.2009.22.4162 DO - 10.1200/JCO.2009.22.4162 ID - Sobrero2009 ER - TY - JOUR AU - Fojo, T. AU - Grady, C. PY - 2009 DA - 2009// TI - How much is life worth: cetuximab, non-small cell lung cancer, and the $440 billion question JO - J Natl Cancer Inst VL - 101 UR - https://doi.org/10.1093/jnci/djp177 DO - 10.1093/jnci/djp177 ID - Fojo2009 ER - TY - JOUR AU - Eichler, H. G. AU - Bloechl-Daum, B. AU - Abadie, E. PY - 2010 DA - 2010// TI - Relative efficacy of drugs: an emerging issue between regulatory agencies and third-party payers JO - Nat Rev Drug Discov VL - 9 UR - https://doi.org/10.1038/nrd3079 DO - 10.1038/nrd3079 ID - Eichler2010 ER - TY - JOUR AU - O'Connor, A. B. PY - 2010 DA - 2010// TI - Building comptive efficacy and tolerability into the FDA approval process JO - JAMA VL - 303 UR - https://doi.org/10.1001/jama.2010.257 DO - 10.1001/jama.2010.257 ID - O'Connor2010 ER - TY - JOUR AU - Breckenridge, A. AU - Woods, K. AU - Walley, T. PY - 2010 DA - 2010// TI - Medicines regulation and health technology assessment JO - Clin Pharmacol Ther VL - 87 UR - https://doi.org/10.1038/clpt.2009.261 DO - 10.1038/clpt.2009.261 ID - Breckenridge2010 ER -